BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMWD
2351
DELISTED
American Woodmark
AMWD
| $58.6K | ﹤0.01% |
1,068
+777
| +267% | +$41.4K |
|
|
OB
2352
DELISTED
Onebeacon Insurance Group Ltd
OB
| $58.6K | ﹤0.01% |
4,036
+3,507
| +663% | +$52.4K |
|
2353
Inogen
INGN
$153M
| $58.4K | ﹤0.01% |
1,309
+1,182
| +931% | +$45.4K |
|
2354
Ingles Markets
IMKTA
$1.66B
| $58.4K | ﹤0.01% |
1,222
+880
| +257% | +$42.5K |
|
|
PRMW
2355
DELISTED
Primo Water Corporation
PRMW
| $58.3K | ﹤0.01% |
5,143
-30,329
| -86% | -$290K |
|
2356
Standard BioTools
LAB
$285M
| $58.3K | ﹤0.01% |
2,410
+1,736
| +258% | +$54.8K |
|
|
CFNL
2357
DELISTED
Cardinal Financial Corp
CFNL
| $58.3K | ﹤0.01% |
2,676
+1,918
| +253% | +$40K |
|
|
IVC
2358
DELISTED
Invacare Corporation
IVC
| $58.3K | ﹤0.01% |
2,693
+1,935
| +255% | +$41K |
|
|
RATE
2359
DELISTED
Bankrate Inc
RATE
| $58.2K | ﹤0.01% |
5,551
+3,084
| +125% | +$37.3K |
|
2360
AtriCure
ATRC
$2.23B
| $58.1K | ﹤0.01% |
2,360
+1,716
| +266% | +$38.3K |
|
|
EPZM
2361
DELISTED
Epizyme, Inc
EPZM
| $58K | ﹤0.01% |
2,417
+2,118
| +708% | +$40.8K |
|
2362
Icon
ICLR
$12.6B
| $57.9K | ﹤0.01% |
+860
| New | +$58K |
|
2363
CareTrust REIT
CTRE
$9.24B
| $57.8K | ﹤0.01% |
4,560
+2,492
| +121% | +$32.6K |
|
|
ITCI
2364
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $57.7K | ﹤0.01% |
1,805
+1,407
| +354% | +$35.7K |
|
|
EGRX
2365
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $57.7K | ﹤0.01% |
+713
| New | +$46.4K |
|
|
PGTI
2366
DELISTED
PGT, Inc.
PGTI
| $57.6K | ﹤0.01% |
3,973
+2,862
| +258% | +$35.5K |
|
|
SASR
2367
DELISTED
Sandy Spring Bancorp Inc
SASR
| $57.4K | ﹤0.01% |
2,053
+1,453
| +242% | +$38.7K |
|
|
STNR
2368
DELISTED
STEINER LEISURE LTD
STNR
| $57.4K | ﹤0.01% |
1,068
+743
| +229% | +$37.5K |
|
|
LADR
2369
Ladder Capital
LADR
$1.27B
| $57.4K | ﹤0.01% |
4,122
+3,673
| +818% | +$52.7K |
|
|
AVTA
2370
DELISTED
Avantax, Inc. Common Stock
AVTA
| $57.3K | ﹤0.01% |
3,547
+2,543
| +253% | +$39.2K |
|
2371
Rayonier Advanced Materials
RYAM
$566M
| $57.1K | ﹤0.01% |
3,512
+2,589
| +280% | +$42.6K |
|
2372
Biglari Holdings Class B
BH
$1.2B
| $57.1K | ﹤0.01% |
207
+144
| +229% | +$37.5K |
|
|
DVAX
2373
DELISTED
Dynavax Technologies
DVAX
| $57.1K | ﹤0.01% |
2,438
+1,818
| +293% | +$39.6K |
|
|
SALE
2374
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $57K | ﹤0.01% |
3,197
+2,466
| +337% | +$47.4K |
|
|
PRFT
2375
DELISTED
Perficient Inc
PRFT
| $56.7K | ﹤0.01% |
2,948
+2,130
| +260% | +$42.5K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.